Dr. Simon Claeys: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Dr. Simon Claeys
Largest movements
- Cash +€184,882
up €184,882 (+53.9%), from €343,034 to €527,916
mainly Net result for the year (+€181,207) and Accrued charges and deferred income (+€6,000)
- Reserves +€181,207
up €181,207 (+57.2%), from €316,546 to €497,753
- Accrued charges and deferred income +€6,000
new in 2025: €6,000
- Gross operating margin -€17,070
down €17,070 (-6.8%), from €251,166 to €234,096
- Taxes -€3,401
down €3,401 (-5.8%), from €58,856 to €55,455
- Financial income +€2,897
up €2,897 (+97.0%), from €2,987 to €5,884
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €382,062 | €562,537 | +€180,475 | +47.2% |
| Fixed assets | 21/28 | €2,959 | €1,983 | -€975 | -33.0% |
| Tangible fixed assets | 22/27 | €2,959 | €1,983 | -€975 | -33.0% |
| Furniture and vehicles | 24 | €2,959 | €1,983 | -€975 | -33.0% |
| Current assets | 29/58 | €379,103 | €560,554 | +€181,451 | +47.9% |
| Amounts receivable within one year | 40/41 | €8,971 | €8,650 | -€322 | -3.6% |
| Trade receivables | 40 | €8,971 | €8,650 | -€322 | -3.6% |
| Current investments | 50/53 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €343,034 | €527,916 | +€184,882 | +53.9% |
| Deferred charges and accrued income | 490/1 | €27,098 | €23,988 | -€3,110 | -11.5% |
| Total equity and liabilities | 10/49 | €382,062 | €562,537 | +€180,475 | +47.2% |
| Equity | 10/15 | €319,546 | €500,753 | +€181,207 | +56.7% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €316,546 | €497,753 | +€181,207 | +57.2% |
| Distributable reserves | 133 | €316,546 | €497,753 | +€181,207 | +57.2% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €62,516 | €61,784 | -€732 | -1.2% |
| Amounts payable within one year | 42/48 | €62,516 | €55,784 | -€6,732 | -10.8% |
| Trade debts | 44 | €2,112 | €654 | -€1,458 | -69.0% |
| Suppliers | 440/4 | €2,112 | €654 | -€1,458 | -69.0% |
| Taxes, remuneration and social security | 45 | €57,960 | €53,690 | -€4,270 | -7.4% |
| Taxes | 450/3 | €57,960 | €53,690 | -€4,270 | -7.4% |
| Other amounts payable | 47/48 | €2,444 | €1,440 | -€1,005 | -41.1% |
| Accrued charges and deferred income | 492/3 | - | €6,000 | +€6,000 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €975 | €975 | = | 0.0% |
| Other operating charges | 640/8 | €1,637 | €1,493 | -€144 | -8.8% |
| Gross operating margin | 9900 | €251,166 | €234,096 | -€17,070 | -6.8% |
| Operating profit (loss) | 9901 | €248,554 | €231,627 | -€16,926 | -6.8% |
| Financial income | 75/76B | €2,987 | €5,884 | +€2,897 | +97.0% |
| Recurring financial income | 75 | €2,987 | €5,884 | +€2,897 | +97.0% |
| Financial charges | 65/66B | €1,094 | €850 | -€244 | -22.3% |
| Recurring financial charges | 65 | €1,094 | €850 | -€244 | -22.3% |
| Profit (loss) for the period before taxes | 9903 | €250,447 | €236,662 | -€13,785 | -5.5% |
| Income taxes | 67/77 | €58,856 | €55,455 | -€3,401 | -5.8% |
| Profit (loss) for the period | 9904 | €191,591 | €181,207 | -€10,384 | -5.4% |
| Profit (loss) for the period to be appropriated | 9905 | €191,591 | €181,207 | -€10,384 | -5.4% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.